Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning
Anticancer peptides (ACPs) are selective and toxic to cancer cells as new anticancer drugs. Identifying new ACPs is time-consuming and expensive to evaluate all candidates’ anticancer abilities. To reduce the cost of ACP drug development, we collected the most updated ACP data to train a convolution...
Main Authors: | Yih-Yun Sun, Tzu-Tang Lin, Wen-Chih Cheng, I-Hsuan Lu, Chung-Yen Lin, Shu-Hwa Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/4/422 |
Similar Items
-
CancerGram: An Effective Classifier for Differentiating Anticancer from Antimicrobial Peptides
by: Michał Burdukiewicz, et al.
Published: (2020-10-01) -
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
by: Anna Lucia Tornesello, et al.
Published: (2020-06-01) -
An Overview of Antimicrobial Peptides as Anticancer Agents
by: Ali Ganji, et al.
Published: (2019-09-01) -
Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside
by: Ameneh Jafari, et al.
Published: (2022-02-01) -
ACPPfel: Explainable deep ensemble learning for anticancer peptides prediction based on feature optimization
by: Mingyou Liu, et al.
Published: (2024-02-01)